| Year |
Citation |
Score |
| 2022 |
Vickers AJ, Elfiky A, Freeman V, Roach M. Race, Biology, Disparities, and Prostate Cancer. European Urology. PMID 35216858 DOI: 10.1016/j.eururo.2022.02.007 |
0.482 |
|
| 2020 |
Freeman VL, Boylan EE, Tilahun NY, Basu S, Kwan MP. Sources of Selection and Information Biases When Using Commercial Database-Derived Residential Histories for Cancer Research. Annals of Epidemiology. PMID 32711052 DOI: 10.1016/J.Annepidem.2020.07.010 |
0.316 |
|
| 2020 |
Fakhoury MQ, Ghorayeb AM, Houlihan MD, Powers RJ, Hurley S, Wille MA, Freeman V, Kim K, Psutka SP, Vidal P, Hollowell CM. Predictive Risk Factors for Continued Smoking after the Diagnosis of a Genitourinary Malignancy. Urology. PMID 32663556 DOI: 10.1016/J.Urology.2020.05.089 |
0.334 |
|
| 2020 |
Freeman VL, Naylor KB, Boylan EE, Booth BJ, Pugach O, Barrett RE, Campbell RT, McLafferty SL. Spatial access to primary care providers and colorectal cancer-specific survival in Cook County, Illinois. Cancer Medicine. PMID 32130791 DOI: 10.1002/Cam4.2957 |
0.371 |
|
| 2019 |
Dobbs RW, Stinson J, Vasavada SR, Caldwell BM, Freeman VL, Garvey DF, Lu J, Moreira DM, Abern MR. Helping Men Find Their Way: Improving Prostate Cancer Clinic Attendance via Patient Navigation. Journal of Community Health. PMID 31713018 DOI: 10.1007/S10900-019-00776-W |
0.431 |
|
| 2019 |
Kim K, Kong A, Flanigan RC, Quek ML, Hollowell CMP, Vidal PP, Branch J, Dean LA, Macias V, Kajadacsy-Balla AA, Fitzgibbon ML, Cintron D, Liu L, Freeman VL. Pre-diagnostic carbohydrate intake and treatment failure after radical prostatectomy for early-stage prostate cancer. Cancer Causes & Control : Ccc. PMID 30729360 DOI: 10.1007/S10552-019-1134-4 |
0.487 |
|
| 2018 |
Donadio JLS, Liu L, Freeman VL, Ekoue DN, Diamond AM, Bermano G. Interaction of NKX3.1 and SELENOP genotype with prostate cancer recurrence. The Prostate. PMID 30582190 DOI: 10.1002/Pros.23752 |
0.534 |
|
| 2018 |
Ekoue DN, Ansong E, Liu L, Macias V, Deaton R, Lacher C, Picklo M, Nonn L, Gann PH, Kajdacsy-Balla A, Prins GS, Freeman VL, Diamond AM. Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer. The Prostate. PMID 29314169 DOI: 10.1002/Pros.23471 |
0.547 |
|
| 2017 |
Freeman VL, Boylan EE, Pugach O, Mclafferty SL, Tossas-Milligan KY, Watson KS, Winn RA. A geographic information system-based method for estimating cancer rates in non-censusĀ defined geographical areas. Cancer Causes & Control : Ccc. PMID 28825153 DOI: 10.1007/S10552-017-0941-8 |
0.371 |
|
| 2017 |
Dobbs RW, Greenwald DT, Wadhwa H, Freeman VL, Abern MR. Is prostate cancer stage migration continuing for black men in the PSA era? Prostate Cancer and Prostatic Diseases. PMID 28094251 DOI: 10.1038/Pcan.2016.68 |
0.507 |
|
| 2016 |
Dobbs R, Greenwald D, Wadhwa H, Freeman V, Abern M. Pd42-08 Is Prostate Cancer Stage Migration Continuing For Black Men In The Psa Era? The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1760 |
0.486 |
|
| 2013 |
Park E, Stacewicz-Sapuntzakis M, Sharifi R, Wu Z, Freeman VL, Bowen PE. Diet adherence dynamics and physiological responses to a tomato product whole-food intervention in African-American men. The British Journal of Nutrition. 109: 2219-30. PMID 23200261 DOI: 10.1017/S0007114512004436 |
0.421 |
|
| 2012 |
Bjurlin MA, Cohn MR, Freeman VL, Lombardo LM, Hurley SD, Hollowell CM. Ethnicity and smoking status are associated with awareness of smoking related genitourinary diseases. The Journal of Urology. 188: 724-8. PMID 22818131 DOI: 10.1016/J.Juro.2012.04.110 |
0.312 |
|
| 2012 |
Murphy AB, Ukoli F, Freeman V, Bennett F, Aiken W, Tulloch T, Coard K, Angwafo F, Kittles RA. 8q24 risk alleles in West African and Caribbean men. The Prostate. 72: 1366-73. PMID 22234922 DOI: 10.1002/Pros.22486 |
0.453 |
|
| 2012 |
Freeman VL, Flanigan RC, Hollowell CM, Branch J, Deane L, Quek M, Vidal PP, Friedman N, Cintron D, Dabbous F, Millbrandt L, Garabedian A, Cleofe J, Gomez SL. Abstract 4443: Body weight status predicts pre-treatment risk of PSA failure in men with clinically localized prostate cancer Cancer Research. 72: 4443-4443. DOI: 10.1158/1538-7445.Am2012-4443 |
0.488 |
|
| 2012 |
Martin IK, Stayner LT, Wilder JP, Mahmoud AM, Murphy AB, Freeman VL. Abstract 3598: The role of adiposity in racial and ethnic disparities in prostate cancer occurrence and progression: A systematic literature review Cancer Research. 72: 3598-3598. DOI: 10.1158/1538-7445.Am2012-3598 |
0.658 |
|
| 2012 |
Xicola RM, Gagnon M, Shaw J, Rodriguez G, Pusatcioglu C, Clark J, James R, Ravella S, Guzman G, Janoski A, Morrissey M, Mraz K, Cerye K, Chaudhry V, Kupfer S, ... ... Freeman V, et al. Abstract 3597: The Chicago Colorectal Cancer Consortium (CCCC) experience: Understanding colorectal cancer disparities Cancer Research. 72: 3597-3597. DOI: 10.1158/1538-7445.Am2012-3597 |
0.39 |
|
| 2012 |
Freeman VL, Barrett RE, Booth BJ, McLafferty SL, Shockley A, Simanis JM, Pauls H, Campbell RT. Abstract A05: Does community-level access to healthcare moderate the adverse effect of community socioeconomic deprivation on prostate and colorectal cancer mortality rates? Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-A05 |
0.483 |
|
| 2012 |
Xicola RM, Gagnon M, Rawson JB, Pusatcioglu C, Clark J, Janoski A, Disharoon A, Morrissey K, Raheem S, Mraz KA, Ravella S, Moran M, Ceryes K, Mijic D, Guzman G, ... ... Freeman V, et al. 497 The Chicago Colorectal Cancer Consortium (CCCC) Experience: Understanding Colorectal Cancer Disparities Gastroenterology. 142: S-107. DOI: 10.1016/S0016-5085(12)60402-8 |
0.365 |
|
| 2011 |
Freeman VL, Ricardo AC, Campbell RT, Barrett RE, Warnecke RB. Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 2150-9. PMID 21784953 DOI: 10.1158/1055-9965.Epi-11-0344 |
0.556 |
|
| 2011 |
Xicola RM, Gagnon M, Ravella S, Douglas G, Rawson JB, Adam G, Brock J, Lidiane G, Cerye K, Bhattacharya T, Patel R, Chaudhry S, Shaw J, Guzman G, Chaudhry V, ... ... Freeman V, et al. Abstract B73: The Chicago Colorectal Cancer Consortium (CCCC), a step forward in understanding colorectal cancer in African Americans Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-B73 |
0.402 |
|
| 2007 |
Kositsawat J, Flanigan RC, Meydani M, Choi YK, Freeman VL. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer. The Journal of Urology. 178: 2391-6; discussion 2. PMID 17936811 DOI: 10.1016/J.Juro.2007.08.005 |
0.508 |
|
| 2007 |
Freeman VL, Flanigan RC, Meydani M. Prostatic fatty acids and cancer recurrence after radical prostatectomy for early-stage prostate cancer. Cancer Causes & Control : Ccc. 18: 211-8. PMID 17216324 DOI: 10.1007/S10552-006-0095-6 |
0.522 |
|
| 2006 |
Kidd LR, Coulibaly A, Templeton TM, Chen W, Long LO, Mason T, Bonilla C, Akereyeni F, Freeman V, Isaacs W, Ahaghotu C, Kittles RA. Germline BCL-2 sequence variants and inherited predisposition to prostate cancer. Prostate Cancer and Prostatic Diseases. 9: 284-92. PMID 16733517 DOI: 10.1038/Sj.Pcan.4500884 |
0.537 |
|
| 2006 |
Bonilla C, Mason T, Long L, Ahaghotu C, Chen W, Zhao A, Coulibaly A, Bennett F, Aiken W, Tullock T, Coard K, Freeman V, Kittles RA. E-cadherin polymorphisms and haplotypes influence risk for prostate cancer. The Prostate. 66: 546-56. PMID 16372334 DOI: 10.1002/Pros.20374 |
0.471 |
|
| 2004 |
Freeman VL, Meydani M, Hur K, Flanigan RC. Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma. Cancer. 101: 2744-54. PMID 15495177 DOI: 10.1002/Cncr.20676 |
0.461 |
|
| 2004 |
Coard KC, Freeman VL. Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West Indies. American Journal of Clinical Pathology. 122: 373-6. PMID 15362366 DOI: 10.1309/3A32-Dtvm-H640-M2Qa |
0.441 |
|
| 2004 |
Freeman VL, Durazo-Arvizu R, Keys LC, Johnson MP, Schafernak K, Patel VK. Racial differences in survival among men with prostate cancer and comorbidity at time of diagnosis. American Journal of Public Health. 94: 803-8. PMID 15117704 DOI: 10.2105/Ajph.94.5.803 |
0.527 |
|
| 2004 |
Freeman VL, Coard KC, Wojcik E, Durazo-Arvizu R. Use of the Gleason system in international comparisons of prostatic adenocarcinomas in blacks. The Prostate. 58: 169-73. PMID 14716742 DOI: 10.1002/pros.10323 |
0.407 |
|
| 2004 |
Coard KC, Freeman VL. Gleason Grading of Prostate Cancer American Journal of Clinical Pathology. 122: 373-376. DOI: 10.1309/Mhcy35Fj296Cllc8 |
0.441 |
|
| 2004 |
Long LO, Ahaghotu CA, Jackson AG, Freeman V, Ewing C, Xu J, Isaacs WB, Kittles RA. 411: Macrophage Scavenger Receptor 1 Haplotype Variation and Prostate Cancer Risk in Populations of African Descent Journal of Urology. 171: 109-109. DOI: 10.1016/S0022-5347(18)37673-0 |
0.488 |
|
| 2003 |
Freeman VL, Durazo-Arvizu R, Arozullah AM, Keys LC. Determinants of mortality following a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems. American Journal of Public Health. 93: 1706-12. PMID 14534226 DOI: 10.2105/Ajph.93.10.1706 |
0.506 |
|
| 2002 |
Kittles RA, Chen W, Panguluri RK, Ahaghotu C, Jackson A, Adebamowo CA, Griffin R, Williams T, Ukoli F, Adams-Campbell L, Kwagyan J, Isaacs W, Freeman V, Dunston GM. CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification? Human Genetics. 110: 553-60. PMID 12107441 DOI: 10.1007/S00439-002-0731-5 |
0.369 |
|
| 2001 |
Freeman VL, Meydani M, Yong S, Pyle J, Durazo-Arvizu R, Liao Y, Flanigan RC, Waters WB. Assessing the effect of fatty acids on prostate carcinogenesis in humans: does self-reported dietary intake rank prostatic exposure correctly? The American Journal of Clinical Nutrition. 73: 815-20. PMID 11273858 DOI: 10.1093/Ajcn/73.4.815 |
0.433 |
|
| 2001 |
Freeman VL, Liao Y, Durazo-Arvizu R, Cooper RS. Height and risk of fatal prostate cancer findings from the National Health Interview Survey (1986 to 1994) Annals of Epidemiology. 11: 22-27. PMID 11164116 DOI: 10.1016/S1047-2797(00)00172-1 |
0.554 |
|
| 2000 |
Freeman VL, Meydani M, Yong S, Pyle J, Flanigan RC, Waters WB, Wojcik EM. Prostatic levels of fatty acids and the histopathology of localized prostate cancer. The Journal of Urology. 164: 2168-72. PMID 11061949 DOI: 10.1016/S0022-5347(05)66991-1 |
0.529 |
|
| 2000 |
Kaufman JS, Millikan R, Poole C, Godley P, Cooper RS, Freeman V. Re: "differences in socioeconomic status and survival among white and black men with prostate cancer". American Journal of Epidemiology. 152: 493-4. PMID 10981465 DOI: 10.1093/Aje/152.5.493 |
0.531 |
|
| 2000 |
Freeman VL, Meydani M, Yong S, Pyle J, Wan Y, Arvizu-Durazo R, Liao Y. Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake American Journal of Epidemiology. 151: 109-118. PMID 10645812 DOI: 10.1093/Oxfordjournals.Aje.A010175 |
0.458 |
|
| 1997 |
Freeman VL, Leszczak J, Cooper RS. Race and the histologic grade of prostate cancer Prostate. 30: 79-84. PMID 9051145 DOI: 10.1002/(Sici)1097-0045(19970201)30:2<79::Aid-Pros2>3.0.Co;2-F |
0.553 |
|
| Show low-probability matches. |